NO20021301L - Anvendelse av CSAIDS ved rinovirusinfeksjon - Google Patents

Anvendelse av CSAIDS ved rinovirusinfeksjon

Info

Publication number
NO20021301L
NO20021301L NO20021301A NO20021301A NO20021301L NO 20021301 L NO20021301 L NO 20021301L NO 20021301 A NO20021301 A NO 20021301A NO 20021301 A NO20021301 A NO 20021301A NO 20021301 L NO20021301 L NO 20021301L
Authority
NO
Norway
Prior art keywords
csaids
rhinovirus infection
symptoms
rhinovirus
infection
Prior art date
Application number
NO20021301A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021301D0 (no
Inventor
Susan B Dillon
Sandra D Griego
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20021301D0 publication Critical patent/NO20021301D0/no
Publication of NO20021301L publication Critical patent/NO20021301L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20021301A 1999-09-17 2002-03-15 Anvendelse av CSAIDS ved rinovirusinfeksjon NO20021301L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15449499P 1999-09-17 1999-09-17
PCT/US2000/025386 WO2001019322A2 (en) 1999-09-17 2000-09-15 Use of csaids in rhinovirus infection

Publications (2)

Publication Number Publication Date
NO20021301D0 NO20021301D0 (no) 2002-03-15
NO20021301L true NO20021301L (no) 2002-05-16

Family

ID=22551566

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021301A NO20021301L (no) 1999-09-17 2002-03-15 Anvendelse av CSAIDS ved rinovirusinfeksjon

Country Status (17)

Country Link
EP (1) EP1223924A4 (cs)
JP (1) JP2003516314A (cs)
KR (1) KR20020032591A (cs)
CN (1) CN1382044A (cs)
AR (1) AR025691A1 (cs)
AU (1) AU7584500A (cs)
BR (1) BR0014041A (cs)
CA (1) CA2385722A1 (cs)
CO (1) CO5200855A1 (cs)
CZ (1) CZ2002939A3 (cs)
HU (1) HUP0204333A3 (cs)
IL (1) IL148329A0 (cs)
NO (1) NO20021301L (cs)
PL (1) PL363116A1 (cs)
TR (1) TR200200673T2 (cs)
WO (1) WO2001019322A2 (cs)
ZA (1) ZA200202060B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7301021B2 (en) 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
WO2002060869A2 (en) * 2000-10-19 2002-08-08 Smithkline Beecham Corporation Use of p38 inhibitors for the treatment of inflammation-enhanced cough
MXPA03003612A (es) 2000-10-23 2003-06-19 Smithkline Beecham Corp Compuestos novedosos.
CA2479737C (en) * 2002-03-20 2011-05-24 Elan Pharma International Ltd. Nanoparticulate compositions of map kinase inhibitors
KR20040101398A (ko) * 2002-04-05 2004-12-02 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 점액 과다분비의 치료방법
EP1534282B1 (en) * 2002-07-09 2006-12-27 Boehringer Ingelheim Pharma GmbH & Co.KG Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
JP4593953B2 (ja) * 2004-03-30 2010-12-08 杏林製薬株式会社 ライノウイルス感染症の予防薬
WO2006017505A2 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
TWI389690B (zh) 2005-03-25 2013-03-21 Glaxo Group Ltd 新穎化合物（一）
PL2276505T3 (pl) * 2008-03-20 2014-01-31 Karobio Ab Sprej do nosa lub krople do nosa do leczenia przeziębienia
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
CN102573886A (zh) * 2009-09-17 2012-07-11 相互制药公司 用抗病毒剂治疗哮喘的方法
GB201010196D0 (en) * 2010-06-17 2010-07-21 Respivert Ltd Methods
GB201010193D0 (en) * 2010-06-17 2010-07-21 Respivert Ltd Medicinal use
US11730760B2 (en) 2011-04-01 2023-08-22 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
US11389663B2 (en) 2011-04-01 2022-07-19 Bioregentech, Inc. Laser assisted wound healing protocol and system
GB201611712D0 (en) 2016-07-02 2016-08-17 Hvivo Services Ltd Methods and compounds for the treatment or prevention of severe or persistent influenza
CA3077499C (en) 2017-10-05 2021-09-21 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
GB201721793D0 (en) * 2017-12-22 2018-02-07 Hvivo Services Ltd Methods and compunds for the treatment or prevention of hypercytokinemia and severe influenza
WO2021216754A1 (en) * 2020-04-21 2021-10-28 Spring Discovery, Inc. Use of p38 mapk inhibitors for prevention and treatment of aging and aging-related disorders and for boosting an immune system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US5656644A (en) * 1994-07-20 1997-08-12 Smithkline Beecham Corporation Pyridyl imidazoles
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use
AP9700912A0 (en) * 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
US6469018B1 (en) * 1999-01-08 2002-10-22 Smithkline Beecham Corporation Compounds

Also Published As

Publication number Publication date
HUP0204333A2 (en) 2003-05-28
WO2001019322A2 (en) 2001-03-22
PL363116A1 (en) 2004-11-15
CN1382044A (zh) 2002-11-27
AR025691A1 (es) 2002-12-11
JP2003516314A (ja) 2003-05-13
HUP0204333A3 (en) 2004-07-28
WO2001019322A3 (en) 2001-10-04
CO5200855A1 (es) 2002-09-27
KR20020032591A (ko) 2002-05-03
NO20021301D0 (no) 2002-03-15
EP1223924A4 (en) 2004-07-14
ZA200202060B (en) 2003-05-28
CA2385722A1 (en) 2001-03-22
CZ2002939A3 (cs) 2002-11-13
TR200200673T2 (tr) 2002-12-23
AU7584500A (en) 2001-04-17
EP1223924A2 (en) 2002-07-24
IL148329A0 (en) 2002-09-12
BR0014041A (pt) 2003-07-15

Similar Documents

Publication Publication Date Title
NO20021301L (no) Anvendelse av CSAIDS ved rinovirusinfeksjon
DE69330403T2 (de) Behandlung und prophylaxe von durch parasiten oder bakterien verursachten erkrankungen
ATE215073T1 (de) Tri-substituierte phenyl-derivate verwendbar als pde iv hemmer
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
AR025964A1 (es) Tratamiento nasal topico
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
ATE451930T1 (de) Verwendung von il-18-hemmern zur behandlung oder prävention von sepsis
TR199800815A2 (en) S�lfonilaminokarbonasitler.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
DE69929464D1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
NO965093L (no) [aÅ-annelerte pyrrolderivater og anvendelse av disse i farmasien
ATE404202T1 (de) Die verwendung von potenten, selektiven und nontoxischen c-kithemmern zur behandlung von interstitieller blasenentzündung
DE60129154D1 (de) Neuartige verbindungen
MEP13308A (en) 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
ES2153113T3 (es) Compuestos de benzotiofeno.
DE60013486D1 (de) Verbindungen
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
DZ3282A1 (fr) Traitement du psoriasis
ATE141053T1 (de) Verwendung von torasemid zur behandlung von hirnödemen
DE60122898D1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer-kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
DE60325275D1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen
DK1042288T3 (da) Tripeptidyl-peptidase inhibitorer
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
ATE294590T1 (de) Verwendung von interleukin-11 zur behandlung von hämoragischem schock

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application